FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person *
Doyle William R.

(Last) (First) (Middle)
2484 BRIARCLIFF RD NE, #22,
SUITE 159

(Street)
ATLANTA GA 30329

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Vystar Corp [ VYST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chairman, President & CEO
3. Date of Earliest Transaction (Month/Day/Year)
10/06/2014
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Warrant (Right to Buy) $ 0.07 10/17/2014   D (1)     28,742   (2) 07/05/2023 Common Stock 28,742 $ 0 0 D  
Common Stock Warrant (Right to Buy) $ 0.05 10/17/2014   A (1)   28,742     (2) 07/05/2023 Common Stock 28,742 $ 0 28,742 D  
Common Stock Warrant (Right to Buy) $ 0.1 10/17/2014   D (1)     13,249   (2) 07/19/2023 Common Stock 13,249 $ 0 0 D  
Common Stock Warrant (Right to Buy) $ 0.05 10/17/2014   A (1)   13,249     (2) 07/19/2023 Common Stock 13,249 $ 0 13,249 D  
Common Stock Warrant (Right to Buy) $ 0.14 10/17/2014   D (1)     16,768   (2) 08/16/2023 Common Stock 16,768 $ 0 0 D  
Common Stock Warrant (Right to Buy) $ 0.05 10/17/2014   A (1)   16,768     (2) 08/16/2023 Common Stock 16,768 $ 0 16,768 D  
Common Stock Warrant (Right to Buy) $ 0.12 10/17/2014   D (1)     28,900   (2) 08/30/2023 Common Stock 28,900 $ 0 0 D  
Common Stock Warrant (Right to Buy) $ 0.05 10/17/2014   A (1)   28,900     (2) 08/30/2023 Common Stock 28,900 $ 0 28,900 D  
Common Stock Warrant (Right to Buy) $ 0.07 10/17/2014   D (1)     58,096   (2) 09/06/2023 Common Stock 58,096 $ 0 0 D  
Common Stock Warrant (Right to Buy) $ 0.05 10/17/2014   A (1)   58,096     (2) 09/06/2023 Common Stock 58,096 $ 0 58,096 D  
Common Stock Warrant (Right to Buy) $ 0.1 10/17/2014   D (1)     14,824   (2) 07/27/2021 Common Stock 14,824 $ 0 0 D  
Common Stock Warrant (Right to Buy) $ 0.05 10/17/2014   D (1)   14,824     (2) 07/27/2021 Common Stock 14,824 $ 0 14,824 D  
Common Stock Warrant (Right to Buy) $ 0.1 10/17/2014   D (1)     33,612   (2) 08/26/2021 Common Stock 33,612 $ 0 0 D  
Common Stock Warrant (Right to Buy) $ 0.05 10/17/2014   A (1)   33,612     (2) 08/26/2021 Common Stock 33,612 $ 0 33,612 D  
Common Stock Warrant (Right to Buy) $ 0.1 10/17/2014   D (1)     33,820   (2) 09/09/2021 Common Stock 33,820 $ 0 0 D  
Common Stock Warrant (Right to Buy) $ 0.05 10/17/2014   A (1)   33,820     (2) 09/09/2021 Common Stock 33,820 $ 0 33,820 D  
Common Stock Warrant (Right to Buy) $ 0.1 10/17/2014   D (1)     50,538   (2) 09/23/2021 Common Stock 50,538 $ 0 0 D  
Common Stock Warrant (Right to Buy) $ 0.05 10/17/2014   A (1)   50,538     (2) 09/23/2021 Common Stock 50,538 $ 0 50,538 D  
Common Stock Warrant (Right to Buy) $ 0.1 10/17/2014   D (1)     41,739   (2) 10/07/2021 Common Stock 41,739 $ 0 0 D  
Common Stock Warrant (Right to Buy) $ 0.05 10/17/2014   A (1)   41,739     (2) 10/07/2021 Common Stock 41,739 $ 0 41,739 D  
Common Stock Warrant (Right to Buy) $ 0.1 10/17/2014   D (1)     40,070   (2) 10/21/2021 Common Stock 40,070 $ 0 0 D  
Common Stock Warrant (Right to Buy) $ 0.05 10/17/2014   A (1)   40,070     (2) 10/21/2021 Common Stock 40,070 $ 0 40,070 D  
Common Stock Warrant (Right to Buy) $ 0.1 10/17/2014   D (1)     28,893   (2) 11/04/2021 Common Stock 28,893 $ 0 0 D  
Common Stock Warrant (Right to Buy) $ 0.05 10/17/2014   A (1)   28,893     (2) 11/04/2021 Common Stock 28,893 $ 0 28,893 D  
Common Stock Warrant (Right to Buy) $ 0.09 10/17/2014   D (1)     81,380 10/16/2014 10/16/2024 Common Stock 81,380 $ 0 0 D  
Common Stock Warrant (Right to Buy) $ 0.05 10/17/2014   A (1)   81,380   10/16/2014 10/16/2024 Common Stock 81,380 $ 0 81,380 D  
Common Stock Warrant (Right to Buy) $ 0.1 10/17/2014   D (1)     73,144 10/16/2014 10/16/2024 Common Stock 73,144 $ 0 0 D  
Common Stock Warrant (Right to Buy) $ 0.05 10/17/2014   A (1)   73,144   10/16/2014 10/16/2024 Common Stock 73,144 $ 0 73,144 D  
Explanation of Responses:
1. The reported transaction involved an amendment of the exercise price of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a replacement warrant.
2. The warrant is exercisable immediately.
Remarks:
Form 3 of 3.
Gerald L. Baxter, Attorney-in-Fact 10/20/2014
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.